The Metastatic Breast Cancer Access (MBC) to Care Act is federal legislation that would immediately end the wait times for someone living with MBC to receive Social Security Disability Insurance and Medicare, benefits that they rely on to live. MBC is an aggressive form of cancer that has spread beyond the breast to nearby organs […]
Ben wanted to do something big to help support breast cancer research. After brainstorming ideas with his mom, Stephanie, he came up with the perfect way to fundraise for breast cancer: a bar mitzvah fundraising campaign.
Research shows there are many risk factors for breast cancer. These risk factors can be related to biology, lifestyle, genetics and more. While being born female and getting older both increase your risk for breast cancer, other factors may reduce your risk. Adding exercise into your routine or limiting alcohol intake are two lifestyle choices […]
For community leaders motivated to help end breast cancer, Susan G. Komen’s ambassador fundraising programs offer dedicated supporters a chance to engage with their networks to fundraise in support of Komen. This story highlights the journeys of three of Komen’s dedicated supporters who inspired others to give back and make a meaningful impact in the fight to end breast cancer.
Walgreens pharmacists can be an important part of a breast cancer patient’s care team, helping to empower patients by providing counseling and education for patients on specialty medications and support medications, as well as helping address concerns with insurance, prior authorizations, copays and drug costs.
Research has shown that exercise can improve overall survival, treatment tolerability and quality of life for women with early-stage breast cancer. But what about women who are living with metastatic breast cancer (MBC)? Through a clinical trial, researchers are exploring whether the addition of exercise to standard treatment could hold promise for women living with […]
When Lisa was diagnosed with stage 1 breast cancer, her wife was pregnant with their first child. Four years later, as they waiting for the birth of their second child, Lisa learned the cancer was back and had metastasized (spread). “It was a gut punch,” she said. “It was like déjà vu all over again.”
In 2022, Heather very nearly cancelled her annual mammogram. If she had, the course of her life would likely have changed dramatically. “I almost skipped it, and it probably would have cost me my life,” Heather said. That mammogram revealed a spot on Heather’s breast. A biopsy confirmed she had breast cancer.
Natalie was diagnosed with triple negative breast cancer in 2023. “This journey has changed me in ways I never imagined. It has taken pieces of me, but it has also revealed a strength I didn’t know I had,” she said. “I’m a mother, a survivor, a fighter, a mentor and someone who has learned to live fully, embracing both the visible and invisible scars that cancer has left behind.”
Brett learned she had breast cancer when her third son was 3 months old. “I was 37 at the time, so I’d never had a mammogram and likely wouldn’t have until I was 40,” Brett said. “I’ve always been healthy, I had no issues with childbirth. Nothing like breast cancer was on my radar.”
In May 2024, Heather learned she had early-stage breast cancer. She has volunteered to be a part of three research studies. “Hopefully I’ll help other women with breast cancer,” she said.
For the past 20 years, people with early estrogen receptor-positive (ER+) breast cancer have received a standard treatment, including hormone therapies like aromatase inhibitors or tamoxifen. While these patients generally have good outcomes after this treatment, they are still at risk for recurrence. As researchers seek more targeted and effective treatments for people with early […]
